Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15001570rdf:typepubmed:Citationlld:pubmed
pubmed-article:15001570lifeskim:mentionsumls-concept:C0206427lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0018338lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0031640lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0040649lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:15001570lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:15001570pubmed:issue19lld:pubmed
pubmed-article:15001570pubmed:dateCreated2004-5-4lld:pubmed
pubmed-article:15001570pubmed:abstractTextTo understand the factors controlling expression of the cGMP phosphodiesterase type 6 (PDE6) genes, we have characterized the promoter of the human PDE6A gene that encodes the catalytic alpha-subunit. In vivo DNase I hypersensitivity assays revealed two sites immediately upstream of the PDE6A core promoter region. Transient transfection assay in Y79 cells of constructs containing varying lengths of the promoter region showed a decrease in promoter activity with increasing length. The most active segment contained a 177-bp upstream sequence including apparent Crx and Nrl transcription factor binding sites. Both Crx and Nrl transactivated the PDE6A promoter in HEK293 cells and showed a >100-fold increase when coexpressed. Coexpression of a dominant negative inhibitor of Nrl abolished Nrl transactivation but had no effect on Crx. DNase I footprinting assays identified three potential Crx binding sites within a 55-bp segment beginning 29 bp upstream of the transcription start point. Mutation of two of these sites reduced reporter gene activity by as much as 69%. Gel shifts showed that all three Crx sites required a TAAT sequence for efficient binding. Consistent with a requirement for Crx and Nrl in Pde6a promoter activity, Pde6a mRNA is reduced by 87% in the retina of Crx(-/-) mice and is undetectable in Nrl(-/-) mice at postnatal day 10. These results establish that both Nrl and Crx are required for full transcriptional activity of the PDE6A gene.lld:pubmed
pubmed-article:15001570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:languageenglld:pubmed
pubmed-article:15001570pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:citationSubsetIMlld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15001570pubmed:statusMEDLINElld:pubmed
pubmed-article:15001570pubmed:monthMaylld:pubmed
pubmed-article:15001570pubmed:issn0021-9258lld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:ZackDonald...lld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:SwaroopAnandAlld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:MearsAlan JAJlld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:RenZhiyongZlld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:ChenShimingSlld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:SwainPrabodh...lld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:PittlerSteven...lld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:ZhangYouwenYlld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:YaoSuxiaSlld:pubmed
pubmed-article:15001570pubmed:authorpubmed-author:WhiteJ...lld:pubmed
pubmed-article:15001570pubmed:issnTypePrintlld:pubmed
pubmed-article:15001570pubmed:day7lld:pubmed
pubmed-article:15001570pubmed:volume279lld:pubmed
pubmed-article:15001570pubmed:ownerNLMlld:pubmed
pubmed-article:15001570pubmed:authorsCompleteYlld:pubmed
pubmed-article:15001570pubmed:pagination19800-7lld:pubmed
pubmed-article:15001570pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
pubmed-article:15001570pubmed:meshHeadingpubmed-meshheading:15001570...lld:pubmed
More...